ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
prism:doi |
10.1038/nrdp.2015.15 |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
dcterms:title |
Obstructive sleep apnoea syndrome |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
rdf:type |
node1 |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
rdf:type |
rdfs:Resource |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
rdf:type |
owl:Thing |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
rdf:type |
prov:Entity |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |
owl:sameAs |
https://semopenalex.org/work/W2441644746 |
ripekg:work/10.1111%2Fjsr.14373Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by <scp>CPAP</scp>: Randomised phase 3 study |
http://purl.org/spar/cito/cites |
ripekg:work/10.1038%2Fnrdp.2015.15Obstructive sleep apnoea syndrome |